Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dierk Thomas

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
British Journal of Pharmacology|May 19, 2004
Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of actionDierk Thomas, Bettina C Hammerling, Kezhong Wu, et al.
Journal of the American College of Cardiology|May 14, 2016
Dilation of the Aorta Ascendens Forms Part of the Clinical Spectrum of HCN4 MutationsAlexa M C Vermeer, Elisabeth M Lodder, Dierk Thomas, et al.
Circulation. Arrhythmia and Electrophysiology|September 14, 2019
Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K<sup>+</sup> Channel-Related Acid-Sensitive K<sup>+</sup> Channel-1) (K<sub>2P</sub>3.1) K<sup>+</sup> Channels Suppresses Atrial Fibrillation and Prevents Electrical RemodelingConstanze Schmidt, Felix Wiedmann, Christoph Beyersdorf, et al.
European Heart Journal|January 7, 2017
Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapyConstanze Schmidt, Felix Wiedmann, Xiao-Bo Zhou, et al.
Circulation|May 9, 2015
Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial FibrillationConstanze Schmidt, Felix Wiedmann, Niels Voigt, et al.
Circulation|March 16, 2016
Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation"Constanze Schmidt, Felix Wiedmann, Niels Voigt, et al.
Scientific Reports|December 21, 2016
Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion BeamsH Immo Lehmann, Christian Graeff, Palma Simoniello, et al.
Circulation. Arrhythmia and Electrophysiology|December 3, 2025
Thyrotropin Directly Affects Cardiac Electrophysiology and Is Associated With AF PrevalenceAnn-Kathrin Rahm, Maximilian N Wunsch, Dominik Seibold, et al.
Basic Research in Cardiology|February 25, 2021
Epigenetic regulation of cardiac electrophysiology in atrial fibrillation: HDAC2 determines action potential duration and suppresses NRSF in cardiomyocytesPatrick Lugenbiel, Katharina Govorov, Pascal Syren, et al.
Circulation. Genomic and Precision Medicine|March 17, 2018
Ion Channel Dysfunctions in Dilated Cardiomyopathy in Limb-Girdle Muscular DystrophyIbrahim El-Battrawy, Zhihan Zhao, Huan Lan, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
British Journal of Pharmacology|May 19, 2004
Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of actionDierk Thomas, Bettina C Hammerling, Kezhong Wu, et al.
Journal of the American College of Cardiology|May 14, 2016
Dilation of the Aorta Ascendens Forms Part of the Clinical Spectrum of HCN4 MutationsAlexa M C Vermeer, Elisabeth M Lodder, Dierk Thomas, et al.
Circulation. Arrhythmia and Electrophysiology|September 14, 2019
Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K<sup>+</sup> Channel-Related Acid-Sensitive K<sup>+</sup> Channel-1) (K<sub>2P</sub>3.1) K<sup>+</sup> Channels Suppresses Atrial Fibrillation and Prevents Electrical RemodelingConstanze Schmidt, Felix Wiedmann, Christoph Beyersdorf, et al.
European Heart Journal|January 7, 2017
Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapyConstanze Schmidt, Felix Wiedmann, Xiao-Bo Zhou, et al.
Circulation|May 9, 2015
Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial FibrillationConstanze Schmidt, Felix Wiedmann, Niels Voigt, et al.
Circulation|March 16, 2016
Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation"Constanze Schmidt, Felix Wiedmann, Niels Voigt, et al.
Scientific Reports|December 21, 2016
Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion BeamsH Immo Lehmann, Christian Graeff, Palma Simoniello, et al.
Circulation. Arrhythmia and Electrophysiology|December 3, 2025
Thyrotropin Directly Affects Cardiac Electrophysiology and Is Associated With AF PrevalenceAnn-Kathrin Rahm, Maximilian N Wunsch, Dominik Seibold, et al.
Basic Research in Cardiology|February 25, 2021
Epigenetic regulation of cardiac electrophysiology in atrial fibrillation: HDAC2 determines action potential duration and suppresses NRSF in cardiomyocytesPatrick Lugenbiel, Katharina Govorov, Pascal Syren, et al.
Circulation. Genomic and Precision Medicine|March 17, 2018
Ion Channel Dysfunctions in Dilated Cardiomyopathy in Limb-Girdle Muscular DystrophyIbrahim El-Battrawy, Zhihan Zhao, Huan Lan, et al.
Pageof 22